Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
暂无分享,去创建一个
Li-Huei Tsai | Ralph A. Nixon | L. Tsai | N. Robakis | R. Nixon | Jie Shen | Jie Shen | S. Pimplikar | Sanjay W. Pimplikar | Nikolaos K. Robakis
[1] Richard D. Kim,et al. Reduced β-Amyloid Production and Increased Inflammatory Responses in Presenilin Conditional Knock-out Mice* , 2004, Journal of Biological Chemistry.
[2] A. Cuervo. Autophagy and aging: keeping that old broom working. , 2008, Trends in genetics : TIG.
[3] C. Chu,et al. Review: Autophagy and neurodegeneration: survival at a cost? , 2010, Neuropathology and applied neurobiology.
[4] J. Schröder,et al. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42 , 2005, Neurobiology of Aging.
[5] Xinran Liu,et al. Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant Mice , 2010, PloS one.
[6] E. Kandel,et al. APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout Mice , 2001, Neuron.
[7] Li-Huei Tsai,et al. A decade of CDK5 , 2001, Nature Reviews Molecular Cell Biology.
[8] Li-Huei Tsai,et al. Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.
[9] Y. Suh,et al. Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl‐terminal fragment of Alzheimer's APP in mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] Deepak Srinivasan,et al. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. , 2010, Human molecular genetics.
[11] B T Hyman,et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.
[12] L. Tsai,et al. Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.
[13] R. Nixon,et al. Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.
[14] R. Nixon,et al. Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. , 2008, The American journal of pathology.
[15] B. Strooper,et al. Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms , 2006, Journal of neurochemistry.
[16] C. Epstein,et al. App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome , 2003, The Journal of Neuroscience.
[17] L. Gan,et al. Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease , 2008, Neuron.
[18] B. Yankner,et al. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Morris,et al. Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.
[20] J. Shioi,et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. , 2003, Cell.
[21] L. Baki,et al. Wild-Type But Not FAD Mutant Presenilin-1 Prevents Neuronal Degeneration by Promoting Phosphatidylinositol 3-Kinase Neuroprotective Signaling , 2008, The Journal of Neuroscience.
[22] D. Bredesen,et al. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain , 2011, Neurobiology of Aging.
[23] D. Kang,et al. Presenilins Mediate Phosphatidylinositol 3-Kinase/AKT and ERK Activation via Select Signaling Receptors , 2005, Journal of Biological Chemistry.
[24] E. Kandel,et al. Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.
[25] A. Cuervo,et al. Autophagy gone awry in neurodegenerative diseases , 2010, Nature Neuroscience.
[26] Richard D. Kim,et al. Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. , 2004, The Journal of biological chemistry.
[27] G. Serban,et al. Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB‐induced Src phosphorylation and signaling , 2006, The EMBO journal.
[28] Nick C Fox,et al. Amyloid, hypometabolism, and cognition in Alzheimer disease , 2007, Neurology.
[29] R. Terry,et al. Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia , 1967, Acta Neuropathologica.
[30] M. Arbel,et al. Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Stiegler,et al. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. , 1998, Cancer research.
[32] S. Pimplikar,et al. The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Mercken,et al. Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein , 2002, The Journal of Biological Chemistry.
[34] T. Ohm,et al. Cholesterol and Tau Protein - Findings in Alzheimer’s and Niemann Pick C’s Disease , 2003, Pharmacopsychiatry.
[35] J. Taylor,et al. The Role of Autophagy in Age-Related Neurodegeneration , 2007, Neurosignals.
[36] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[37] Ralph A. Nixon,et al. Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[38] S. Pimplikar,et al. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.
[39] R. J. Kelleher,et al. Indirect Regulation of Presenilins in CREB-mediated Transcription* , 2009, Journal of Biological Chemistry.
[40] D. Westaway,et al. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.
[41] A. Georgakopoulos,et al. Peptide EphB2/CTF2 Generated by the γ-Secretase Processing of EphB2 Receptor Promotes Tyrosine Phosphorylation and Cell Surface Localization of N-Methyl-d-aspartate Receptors* , 2009, The Journal of Biological Chemistry.
[42] L. Polito,et al. Early-Onset Alzheimer Disease in an Italian Family With Presenilin-1 Double Mutation E318G and G394V , 2008, Alzheimer disease and associated disorders.
[43] N. Robakis. An Alzheimer's disease hypothesis based on transcriptional dysregulation , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[44] A. Verma,et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study , 2008 .
[45] S. Pimplikar,et al. APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation , 2010, PloS one.
[46] Petti T. Pang,et al. Opposing Roles of Transient and Prolonged Expression of p25 in Synaptic Plasticity and Hippocampus-Dependent Memory , 2005, Neuron.
[47] David S. Park,et al. Role of Cdk5-Mediated Phosphorylation of Prx2 in MPTP Toxicity and Parkinson's Disease , 2007, Neuron.
[48] L. Mucke,et al. Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease , 2006, Neuron.
[49] M. Ohno,et al. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.
[50] M. Scarpa,et al. Pathophysiology of neuropathic lysosomal storage disorders , 2010, Journal of Inherited Metabolic Disease.
[51] Jie Shen,et al. Regulation of CRE-dependent transcription by presenilins: prospects for therapy of Alzheimer's disease. , 2006, Trends in pharmacological sciences.
[52] P. Marambaud,et al. Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation , 2004, Genes, brain, and behavior.
[53] R. J. Kelleher,et al. A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of γ-Secretase Activity* , 2010, The Journal of Biological Chemistry.
[54] K. Wang,et al. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. , 2000, Biochemical and biophysical research communications.
[55] Kerry A. Mullaney,et al. Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition , 2009, Proceedings of the National Academy of Sciences.
[56] L. Tsai,et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.
[57] Marc Tessier-Lavigne,et al. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases , 2009, Nature.
[58] D L Price,et al. Alzheimer's disease: genetic studies and transgenic models. , 1998, Annual review of genetics.
[59] M. Bothwell,et al. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. , 2005, Journal of neurochemistry.
[60] L. Baki,et al. PS1 activates PI3K thus inhibiting GSK‐3 activity and tau overphosphorylation: effects of FAD mutations , 2004, The EMBO journal.
[61] T. Südhof,et al. Presenilins are Essential for Regulating Neurotransmitter Release , 2009, Nature.
[62] T. Deerinck,et al. Re‐Evaluation of the Structural Organization of Neuritic Plaques in Alzheimer's Disease , 1993 .
[63] P. L. Peng,et al. Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity , 2008, Neuron.
[64] Tony Kouzarides,et al. Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.
[65] Thomas C. Südhof,et al. A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60 , 2001, Science.
[66] R. Neve,et al. Transgenic mice expressing APP-C100 in the brain , 1996, Neurobiology of Aging.
[67] R. J. Kelleher,et al. The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism , 2007, Proceedings of the National Academy of Sciences.
[68] R. Neve,et al. Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein , 1996, The Journal of Neuroscience.
[69] S. Pimplikar,et al. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain , 2005, The Journal of cell biology.
[70] Y. Suh,et al. Carboxyl‐terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[71] Ahmad Salehi,et al. Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration , 2006, Neuron.
[72] R. Nixon,et al. Neurodegenerative lysosomal disorders: A continuum from development to late age , 2008, Autophagy.
[73] Nektarios Tavernarakis,et al. Can autophagy promote longevity? , 2010, Nature Cell Biology.
[74] L. Kudo,et al. Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy , 2009, Proceedings of the National Academy of Sciences.
[75] K. Ishiguro,et al. Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25* , 2000, The Journal of Biological Chemistry.
[76] T. Südhof,et al. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. , 2001, Science.
[77] M. Shapiro,et al. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein , 1997, Nature.
[78] F. Pasquier,et al. A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.
[79] L. Tjernberg,et al. Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease , 2005, The Journal of cell biology.
[80] C. Glabe. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease , 2001, Journal of Molecular Neuroscience.
[81] B. Strooper,et al. Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.
[82] T. Südhof,et al. Conditional Forebrain Inactivation of Nicastrin Causes Progressive Memory Impairment and Age-Related Neurodegeneration , 2009, The Journal of Neuroscience.
[83] M. Bothwell,et al. Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment , 2005 .
[84] S. Paik,et al. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein , 2006, Neurobiology of Disease.
[85] Brian David Dynlacht,et al. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. , 2002, Genes & development.
[86] A. Georgakopoulos,et al. Ligand Binding and Calcium Influx Induce Distinct Ectodomain/γ-Secretase-processing Pathways of EphB2 Receptor* , 2007, Journal of Biological Chemistry.
[87] Jie Shen,et al. Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases , 2010, Neurodegenerative Diseases.
[88] R. Neve,et al. Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression , 2010, Biological Psychiatry.
[89] J. Shioi,et al. A CBP Binding Transcriptional Repressor Produced by the PS1/ϵ-Cleavage of N-Cadherin Is Inhibited by PS1 FAD Mutations , 2003, Cell.
[90] Jayanta Debnath,et al. Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease , 2010, PloS one.
[91] Bryan Maloney,et al. Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing , 2008, Neuron.
[92] N. Robakis. Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives , 2011, Neurobiology of Aging.
[93] Yong Shen,et al. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain , 2009, Proceedings of the National Academy of Sciences.
[94] H. Rusinek,et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[95] Ralph A. Nixon,et al. Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study , 2005, Journal of neuropathology and experimental neurology.
[96] Jerry H. Wang,et al. Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors , 2003, Nature Neuroscience.
[97] D. Rubinsztein,et al. Autophagy, a guardian against neurodegeneration , 2010, Seminars in cell & developmental biology.
[98] J. Bibb. Faculty Opinions recommendation of Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. , 2008 .
[99] T. Südhof,et al. Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction , 2010, Journal of neurochemistry.
[100] D. O’Carroll,et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.
[101] Z. Kouchi,et al. FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Aβ , 2006, Journal of neurochemistry.